However, our Spotlight: Americans for Medical Progress/Vital Role of Animals in Research Dear FDA Matters readers: This column is the second in a new series that puts a spotlight on causes and organizations that affect FDA and the FDA stakeholder community
Natural product-derived treatments for attention-deficit/hyperactivity disorder: Safety, efficacy, and therapeutic potential of combination therapy
Mullard A (2023) 2022 FDA approvals
Media appearances featuring our founder, Amanda Bonello, are made in her personal capacity and do not constitute official statements or endorsements by the nonprofit
By combining GHK-Cu, BPC-157, TB-500, and KPV into a single synergistic formula, it simultaneously drives collagen remodeling, promotes new blood vessel formation, accelerates cellular migration to damaged tissue, and keeps systemic inflammation in check
Chen Y-T, Kao C-J, Huang H-Y, Huang S-Y, Chen C-Y, Lin Y-S, Wen Z-H, Wang H-MD